|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
+0.14% | +29.68% |
| 2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
| 2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Stallergenes Greer Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 325.09 million compared to EUR 301.45 million a year ago. Revenue was EUR 328.06 million compared to EUR 303.91 million a year ago.
Net income was EUR 60.67 million compared to EUR 33.71 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.68% | 0 | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
STALLERGENES GREER 
